Enzo Biochem Inc

NYSE ENZ

Download Data

Enzo Biochem Inc Capital Stock Change 3 year CAGR for the quarter ending September 19, 2024

Enzo Biochem Inc Capital Stock Change 3 year CAGR is NA for the quarter ending September 19, 2024. Capital Stock Change is the net change in the company's capital stock during a specific period, including the issuance or retirement of shares. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.
NYSE: ENZ

Enzo Biochem Inc

CEO Mr. Hamid Erfanian
IPO Date June 12, 1980
Location United States
Headquarters 81 Executive Blvd., Farmingdale, NY, United States, 11735
Employees 179
Sector Healthcare
Industry Diagnostics & research
Description

Enzo Biochem, Inc. develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. It also provides AMPIVIEW in situ hybridization probes for enhanced detection of low expressed targets useful in the growing spatial biology space; reagents and assays for cell and gene therapy research and development; POLYVIEW PLUS Enhanced Immunohistochemistry platform, offers solutions within the area of anatomical pathology through optimized assays; Enhanced Immunoassays, pushing sensitivity to expand immunoassay applications for basic research, bioprocess, and diagnostics; AMPIPROBE, a nucleic acid amplification platform; and Axxora.com, a proven distribution platform for original manufacturers of innovative research reagents. The company's proprietary products and technologies in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. It markets its products and services through its direct sales force and a network of distributors. The company was incorporated in 1976 and is headquartered in Farmingdale, New York.

Similar companies

FONR

Fonar Corporation

NA

NA

SERA

Sera Prognostics Inc

NA

NA

OLK

Olink Holding AB ADR

NA

NA

DRIO

DarioHealth Corp

NA

NA

XGN

Exagen Inc

NA

NA

BDSX

Biodesix Inc

NA

NA

StockViz Staff

September 19, 2024

Any question? Send us an email